Skip to content

TRIUS THERAPEUTICS INC

CIK 0001356857

← back to feed
Revenue (TTM)
$15.22M
−13.7% YoY Q2 Aug 2013
Net Income (TTM)
−$69.06M
−195.5% YoY Q2 Aug 2013
EPS Diluted (TTM)
−$0.36
+21.7% YoY Q2 Aug 2013
Gross Margin
—
Q2 Aug 2013
Operating Margin
-430.6%
Q2 Aug 2013
Net Margin
-453.9%
Q2 Aug 2013
Free Cash Flow (TTM)
−$50.11M
Q2 Aug 2013
Cash
$15.32M
Q2 Aug 2013
Total Debt
—
Q2 Aug 2013
Shares Outstanding
48.27M sh
Q2 Aug 2013

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings